$1.76
▼ -0.6% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
Overview
52-week range
$1.60
$4.67
5% of range
Avg surprise (last 3)
+17.0%
Avg reaction (last 2)
+1.2%
50% positive
Latest IV / EM
37%
EM ±8.5% · $2 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.05 | $-0.08 | +37.5% | +37.5% | -0.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.07 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.10 | $-0.08 | -25.0% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.08 | $-0.13 | +38.5% | — | +3.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.20 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.17 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.17 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.21 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.25 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.08 | -$0.10 | +20.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $103,000 | — | — | — | — | — | — | — |
| Gross profit | $2,000 | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-4M | $-4M | $-3M | — | $-3M | $-3M |
| Net income | $-4M | — | $-4M | $-4M | $-3M | — | $-3M | $-2M |
| EPS (diluted) | $-0.05 | — | $-0.07 | $-0.10 | $-0.08 | — | $-0.20 | $-0.17 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $4M | $7M | $4M | $3M | $3M | $479,000 | $2M |
| Inventory | $2M | $584,000 | — | — | — | — | — | — |
| Total current assets | $77M | $80M | $81M | $33M | $31M | $6M | $5M | $7M |
| Total assets | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $4M | $4M | $3M | $2M | $3M | $1M | $1M |
| Total equity | $74M | $78M | $78M | $30M | $29M | $4M | $4M | $6M |